1-o-hexadecyl-2-n-methylcarbamol -sn-glycerol-3-phosphocholine has been researched along with Eczema, Atopic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al-Hassani, M; Billings, SD; Howard, KM; Ishii, S; Mousdicas, N; Perkins, SM; Shimizu, T; Travers, JB; Yi, Q; Zhang, Q | 1 |
1 other study(ies) available for 1-o-hexadecyl-2-n-methylcarbamol -sn-glycerol-3-phosphocholine and Eczema, Atopic
Article | Year |
---|---|
Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor.
Topics: Animals; Calcium; Cell Line; Dermatitis, Atopic; Dinitrofluorobenzene; Drug Hypersensitivity; Drug Synergism; Humans; Hypersensitivity, Delayed; Inflammation; Interleukin-10; Lipopolysaccharides; Mice; Mice, Knockout; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Skin; Staphylococcal Infections; Staphylococcus aureus; Teichoic Acids; Th1 Cells; Th2 Cells | 2005 |